ICD-10 Coding for Angiosarcoma(C49.9, C44.5)
Complete ICD-10-CM coding and documentation guide for Angiosarcoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Angiosarcoma
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C49.9 | Malignant neoplasm of connective and soft tissue, unspecified | Use when angiosarcoma is confirmed in soft tissue without a specified site. |
|
| C44.5 | Malignant neoplasm of skin | Use for angiosarcoma primarily affecting the skin. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for angiosarcoma
Essential facts and insights about Angiosarcoma
Primary ICD-10-CM Codes for angiosarcoma
Decision Criteria
clinical Criteria
- Confirmed diagnosis of angiosarcoma in soft tissue
Applicable To
- Primary angiosarcoma of soft tissue
Excludes
- Benign neoplasms of soft tissue
Clinical Validation Requirements
- Histological confirmation of angiosarcoma
- Immunohistochemical markers such as CD31, CD34
Code-Specific Risks
- Misclassification with benign soft tissue tumors
Coding Notes
- Ensure histological confirmation before coding.
C44.5 - Malignant neoplasm of skin
Use for angiosarcoma primarily affecting the skin.
Applicable To
- Cutaneous angiosarcoma
Excludes
- Melanoma of skin
Clinical Validation Requirements
- Histological confirmation with skin biopsy
- Immunohistochemical markers such as CD31, CD34
Coding Notes
Ensure proper site documentation.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Angiosarcoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C49.9.
Impact
Clinical: Inaccurate treatment planning., Regulatory: Non-compliance with documentation standards., Financial: Potential loss of reimbursement for metastatic treatment.
Mitigation Strategy
Ensure all metastatic sites are documented.
Impact
Reimbursement: Incorrect site coding can lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate data for epidemiological studies.
Mitigation Strategy
Verify the primary site of the tumor before coding.
Impact
Incorrect site coding can lead to audit flags.
Mitigation Strategy
Verify site with imaging and pathology before coding.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Angiosarcoma, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Angiosarcoma
Use these documentation templates to ensure complete and accurate documentation for Angiosarcoma. These templates include all required elements for proper coding and billing.
Radiation-induced angiosarcoma
Specialty: OncologyRequired Elements
- Patient history of radiation
- Biopsy results
- Immunohistochemical markers
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Angiosarcoma? Ask your questions below.